F. Vaufrey

发表

6‐[18F]Fluoro‐L‐DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor

C. Crouzel, F. Dollé, S. Demphel, 1998 .

In vivo quantification of localized neuronal activation and inhibition in the rat brain using a dedicated high temporal-resolution β+-sensitive microprobe

Philippe Hantraye, Lydie Ploux, Frédéric Pain, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Semiselective POCE NMR spectroscopy

R. Roussel, G. Bloch, P. Henry, 2000, Magnetic resonance in medicine.

Synthesis of a fluorine-18-labelled derivative of 6-nitroquipazine, as a radioligand for the in vivo serotonin transporter imaging with PET.

C. Crouzel, M. Delaforge, Y. Bramoullé, 2002, Bioorganic & medicinal chemistry.

Synthesis of 2‐[18F]fluoro‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors

C. Crouzel, F. Dollé, H. Valette, 1998 .

A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imaging

C. Crouzel, B. Tavitian, F. Dollé, 1997 .

Frequency-shift based detection of BMS contrast agents using SSFP: potential for MRA.

D. Le Bihan, J. Dubois, F. Lethimonnier, 2005, Magnetic resonance imaging.

Conformation in solution of carboxylic ionophore cationomycin: acid form and Li+, Na+, K+, Rb+, Cs+, NMe4+ complexes

F. Vaufrey, G. Jeminet, G. Dauphin, 1993 .

General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies.

C. Crouzel, B. Tavitian, F. Dollé, 2000, Bioconjugate chemistry.

Fluorine-18 labeling of oligonucleotides bearing chemically—modified ribose—phosphate backbones

C. Crouzel, B. Tavitian, F. Dollé, 2000 .

Magnetization transfer characteristics in atherosclerotic plaque components assessed by adapted binomial preparation pulses

M. Pachot-Clouard, F. Vaufrey, L. Darrasse, 1998, Magnetic Resonance Materials in Physics, Biology and Medicine.

Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging.

C. Crouzel, F. Dollé, H. Valette, 1999, Bioorganic & medicinal chemistry.

Synthesis and preliminary evaluation of a carbon‐11‐labelled agonist of the α7 nicotinic acetylcholine receptor

C. Crouzel, F. Dollé, H. Valette, 2001 .

Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.

C Crouzel, J Sandell, C. Crouzel, 1999, Nuclear medicine and biology.

2-, 3- and 4-[18F]Fluoropyridine by no-carrier-added nucleophilic aromatic substitution with K[18F]F-K222- a comparative study: 2-, 3- and 4-[18F] FLUOROPYRIDINE

F. Dollé, F. Hinnen, F. Vaufrey, 2003 .

2‐[18F]fluoropyridines by no‐carrier‐added nucleophilic aromatic substitution with [18F]FK‐K222—a comparative study

C. Crouzel, F. Dollé, F. Vaufrey, 1999 .

Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.

C Crouzel, C. Crouzel, H. Valette, 1999, Journal of medicinal chemistry.

Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart.

C. Crouzel, K. Någren, C. Halldin, 2001, Bioorganic & medicinal chemistry.

Bioconversion of monensin by a soil bacterium, Sebekia benihana.

A. Delort, F. Vaufrey, G. Jeminet, 1990, The Journal of antibiotics.

Up‐regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251‐infected macaques without major brain involvement

F. Condé, D. Dormont, F. Chrétien, 2004, Journal of neurochemistry.

Synthesis of [11C]atipamezole, a potential PET ligand for the α2-adrenergic receptor in the brain

C. Crouzel, Y. Bramoullé, F. Dollé, 2002 .

Carbon‐11 labelling of the α‐2 antagonist atipamezole

C. Crouzel, Y. Bramoullé, F. Dollé, 2001 .

NMR measurement of brain oxidative metabolism in monkeys using 13C‐labeled glucose without a 13C radiofrequency channel

V. Slavov, J. Valette, G. Bloch, 2004, Magnetic resonance in medicine.

Synthesis of a [6-pyridinyl-18F]-labelled fluoro derivative of WAY-100635 as a candidate radioligand for brain 5-HT1A receptor imaging with PET.

C. Halldin, V. Pike, F. Dollé, 2003, Bioorganic & medicinal chemistry.

Preparation of 4- and 6-[76Br] bromometaraminol, two potential radiotracers for the study of the myocardial norepinephrine neuronal reuptake system with pet

C. Crouzel, K. Någren, C. Halldin, 1997 .

Analogs of Monensin with a Modified C25–C26 Moiety: Na+/K+ Selectivity and Biological Activity

F. Vaufrey, G. Jeminet, G. Dauphin, 1990 .

Glycolysis versus TCA Cycle in the Primate Brain as Measured by Combining 18F-FDG PET and 13C-NMR

M. Grégoire, R. Maroy, J. Valette, 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Decreased TCA cycle rate in the rat brain after acute 3‐NP treatment measured by in vivo1H‐{13C} NMR spectroscopy

G. Bloch, E. Brouillet, P. Hantraye, 2002, Journal of neurochemistry.

Early N-Acetylaspartate Depletion Is a Marker of Neuronal Dysfunction in Rats and Primates Chronically Treated with the Mitochondrial Toxin 3-Nitropropionic Acid

F. Condé, G. Bloch, E. Brouillet, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand (11C)raclopride from (11C)methyl triflate

Christer Halldin, Kjell Någren, Johan Sandell, 1999 .

Synthesis and 11C‐labelling of two selective high affinity nicotinic cholinergic agonists for evaluation as radioligands for PET studies

C. Crouzel, F. Dollé, H. Valette, 1996 .